Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI:RCT

Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201704002212265

Enrollment

106

Registered

2017-04-15

Start date

2017-04-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Assisted reproduction

Interventions

Gonadotropin releasing hormone flare-up

Gonadotropin releasing hormone antagonist

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: - Regular menstrual cycle (21-35 days duration), - body mass index (BMI) less than 30 kg/m2 - poor ovarian response according to Bologna Criteria

Exclusion criteria

Exclusion criteria: - systemic disease e.g. diabetes or endocrinal disease e.g. polycystic ovaries - uterine pathology e.g. submucous fibroid polyp or fibroid, and those male factor

Design outcomes

Primary

Measure	Time frame
Number of retrieved oocytes	—

Secondary

Measure	Time frame
Fertilization rate;Metaphase II oocytes;Embryo quality;Number of transferred embryos;Pregnancy rate;Miscarriage rate	—

Countries

Egypt

Contacts

Public ContactHaitham Torky

October 6th University

haithamtorky@yahoo.com+201001230161

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026